Co announces FDA and European CE Mark approvals to expand the capabilities of its Frontier II cardiac resynchronization therapy pacemaker to include QuickOpt Timing Cycle Optimization, giving ...
Risk of cardiac implantable electronic device (CIED) infection and resulting mortality hinged on the timing and extent of infection, which may ultimately come down to the type of procedure that the ...
Pacemaker implantation may include a single chamber for chronic atrial fibrillation or dual chamber for paroxysmal or persistent atrial fibrillation. The timing of the AVJ ablation in regards to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback